Skip to main content

Month: September 2023

Elicio Therapeutics Receives $2.6 Million Grant from the Gastro-Intestinal (GI) Research Foundation to Fund Research for Two Therapeutic Cancer Vaccines

Funds will advance research into ELI-007, a mutant BRAF-peptide vaccine, and ELI-008, a p53 hotspot mutation-peptide vaccine, with the aim of developing multivalent cancer vaccines targeting several mutationsThis $2.6 million grant is an addition to the $2.8 million that GIRF awarded Elicio in September 2022BOSTON, Sept. 07, 2023 (GLOBE NEWSWIRE) — Elicio Therapeutics, Inc. (NASDAQ: ELTX, “Elicio Therapeutics” or “Elicio”), a clinical-stage biotechnology company developing a pipeline of novel immunotherapies for the treatment of cancer, today announced that it has been awarded a $2.6 million grant from the GI Research Foundation in Chicago to fund research for two therapeutic cancer vaccines, ELI-007 and ELI-008. This $2.6 million grant is an addition to the $2.8 million that it awarded Elicio in September 2022. Funds will...

Continue reading

4DMT Announces First Patient Enrolled in 4D-150 Phase 2 SPECTRA Clinical Trial in DME, and Expansion of 4D-150 Phase 2 Stage in PRISM Clinical Trial in Wet AMD

First patient has been enrolled in the Dose Confirmation stage (n=18) of the Phase 2 SPECTRA clinical trial for intravitreal 4D-150 in patients with diabetic macular edemaFirst patient enrolled in Population Extension cohort of Phase 2 stage of PRISM clinical trial in wet AMD (n=up to 45) to evaluate intravitreal 4D-150 in patients with lower anti-VEGF need compared with initial cohortsAll PRISM patient cohorts to inform pivotal clinical trial design for 4D-150; FDA feedback on Phase 3 design expected in Q4 2023 with update expected in Q1 2024Initial interim data for SPECTRA Dose Confirmation and PRISM Population Extension cohort expected in 2024; guidance for randomized Phase 2 stage (n=50) in highest anti-VEGF need patients on-track for H1 2024EMERYVILLE, Calif., Sept. 07, 2023 (GLOBE NEWSWIRE) — 4D Molecular Therapeutics (Nasdaq:...

Continue reading

Copper Lake Announces Updated Mineral Resource Estimate For The Norton Lake Nickel-Copper-Cobalt-PGE Deposit 1.96 Mt Measured & Indicated At 1.07% NiEq

Mineral Resource EstimateMineral Resource EstimateTORONTO, Sept. 07, 2023 (GLOBE NEWSWIRE) — Copper Lake Resources Ltd. (TSX-V: CPL, Frankfurt: WOI, OTC: WTCZF) (“Copper Lake” or the “Company”) is pleased to announce an updated Mineral Resource Estimate (“MRE”) prepared in accordance with National Instrument 43-101, Standard for Disclosure for Mineral Projects (“NI 43-101”) for its Norton Lake nickel-copper-cobalt-platinum group element deposit (the “Deposit”), situated 50 km northeast of Fort Hope and approximately 413 km northeast of Thunder Bay in northern Ontario. Highlights Include:Open pit and underground Measured and Indicated Resources of 1,957,368 tonnes at an average grade of 0.67% Ni, 0.66% Cu, 321 ppm Co, 0.49 g/t Pt, 0.17 g/t Pd (1.07% NiEq) and containing 29.1Mlbs of nickel and 28.3Mlbs of copper. Open...

Continue reading

ITW Announces CEO Succession Plan

Vice Chairman Christopher A. O’Herlihy Named President and Chief Executive Officer E. Scott Santi Will Become Non-Executive Chairman of the Board Succession Plan Supports Continued Advancement of ITW’s Enterprise Strategy and Differentiated Long-Term Performance GLENVIEW, Ill., Sept. 07, 2023 (GLOBE NEWSWIRE) — Illinois Tool Works Inc. (NYSE: ITW), a global multi-industry manufacturing leader, today announced a succession plan that capitalizes on the strength and depth of the ITW leadership team. Christopher A. O’Herlihy, currently Vice Chairman of ITW, will become President and Chief Executive Officer (CEO) and a member of the ITW Board of Directors, effective January 1, 2024. E. Scott Santi, ITW’s CEO since 2012, will step down as CEO and will remain Chairman of the ITW Board until March 1, 2024, at which time he will become...

Continue reading

Tenable Increases Focus on Cloud Security With Agreement to Acquire CNAPP Vendor Ermetic

Acquisition expands Tenable’s capabilities to unify visibility, assessment and remediation across infrastructure and identities both in the cloud and on-premises COLUMBIA, Md., Sept. 07, 2023 (GLOBE NEWSWIRE) — Tenable Holdings, Inc. (“Tenable”) (Nasdaq: TENB), the Exposure Management company, today announced that it has signed a definitive agreement to acquire Ermetic Ltd. (“Ermetic”), a fully integrated cloud-native application protection platform (CNAPP) company, and a leading provider of cloud infrastructure entitlement management (CIEM). Tenable intends to integrate these capabilities into its Tenable One Exposure Management Platform to deliver market-leading contextual risk visibility, prioritization and remediation across infrastructure and identities, both on-premise and in the cloud. Ermetic’s CNAPP delivers in-depth contextual...

Continue reading

OneWater Marine Inc. Announces Acquisition of Harbor Pointe Marina

Acquisition enhances footprint in Southeastern U.S. BUFORD, Ga., Sept. 07, 2023 (GLOBE NEWSWIRE) — OneWater Marine Inc. (NASDAQ: ONEW) (“OneWater” or the “Company”) announced today that it has acquired Harbor Pointe Marina, which further expands the Company’s presence on Alabama’s Lake Martin and enhances new and pre-owned boat sales, finance, and parts and services offerings. “Harbor Pointe Marina presents an exciting, low-risk opportunity to assume a dealership operation at virtually no cost. Furthermore, OneWater’s proven dealership integration and growth strategies enables us to expand the product offering available to Harbor Pointe Marina’s customers and broaden our reach in an attractive boating market,” said Austin Singleton, Chief Executive Officer for OneWater. “The M&A environment continues to pick up steam, and...

Continue reading

BridgeBio Pharma to Participate in the Morgan Stanley 21st Annual Global Healthcare Conference

PALO ALTO, Calif., Sept. 07, 2023 (GLOBE NEWSWIRE) — BridgeBio Pharma, Inc. (Nasdaq: BBIO) (“BridgeBio” or the “Company”), a commercial-stage biopharmaceutical company focused on genetic diseases and cancers, today announced that members of its management team will present at the Morgan Stanley 21st Annual Global Healthcare Conference in New York, NY on Tuesday, September 12 at 10:50 am ET. To access the live webcast of BridgeBio’s presentation, please visit the “Events & Presentations” page within the Investors section of the BridgeBio website at http://investor.bridgebio.com. A replay of the webcast will be available on the BridgeBio website for 90 days following the event. About BridgeBio Pharma, Inc.BridgeBio Pharma, Inc. (BridgeBio) is a commercial-stage biopharmaceutical company founded to discover, create, test, and...

Continue reading

Janover Inc. Appoints Finance Veteran Bruce S. Rosenbloom, CPA as its Chief Financial Officer

Boca Raton, FL, Sept. 07, 2023 (GLOBE NEWSWIRE) — Janover Inc. (Nasdaq: JNVR) (“Janover” or the “Company”), an AI-enabled B2B fintech marketplace connecting commercial property borrowers and lenders with a human touch, today announced the appointment of Bruce S. Rosenbloom, CPA as Chief Financial Officer, effective September 07, 2023. Mr. Rosenbloom assumes the responsibilities formerly held by Mr. Patrick Stinus, Senior Vice President and Interim Chief Financial Officer, who resigned from his position(s) with the Company effective September 6, 2023. Mr. Rosenbloom brings almost 27 years of accounting and corporate finance experience working with public and private companies. Most recently, Mr. Rosenbloom served as the Chief Financial Officer and Treasurer of PetMed Express, Inc. (Nasdaq: PETS) (“PetMed”). During his near...

Continue reading

NFI delivers strongest FTA Low-No and Buses and Bus Facilities grant performance ever, as named partner on more than $200 million in grants

September 2023: NFI delivers strongest FTA Low-No and Buses and Bus Facilities grant performance ever, as named partner on more than $200 million in grantsSeptember 2023: NFI delivers strongest FTA Low-No and Buses and Bus Facilities grant performance ever, as named partner on more than $200 million in grantsST. CLOUD, Minn., Sept. 07, 2023 (GLOBE NEWSWIRE) — (TSX: NFI, OTC: NFYEF, TSX: NFI.DB) NFI Group Inc. (NFI), a leading independent bus and coach manufacturer and a leader in electric mass mobility solutions, today announced that its subsidiary, New Flyer of America Inc. (New Flyer), is the partner of choice in over $207 million in competitive grant awards through the Federal Transit Administration’s (FTA) 2023 Low- or No-Emission (Low-No) and Buses and Bus Facilities (BBF) programs. This is New Flyer’s best Low-No...

Continue reading

Watsco to Present at the 11th Annual Morgan Stanley Laguna Conference on September 13, 2023

MIAMI, Sept. 07, 2023 (GLOBE NEWSWIRE) — Watsco, Inc. (NYSE: WSO) announced today that Barry Logan, Executive Vice President, is scheduled to speak at Morgan Stanley’s 11th Annual Laguna Conference on Wednesday, September 13, 2023 at 10:35 a.m. (EDT). Internet users can listen to a live webcast of the presentation at the Investor Relations section of Watsco’s website at www.watsco.com. About Watsco Watsco operates the largest distribution network for heating, air conditioning and refrigeration (HVAC/R) products with locations in the United States, Canada, Mexico and Puerto Rico, and on an export basis to Latin America and the Caribbean. Watsco estimates that over 350,000 contractors and technicians visit or call one of its 689 locations each year to get information, obtain technical support and buy products. Our business is focused...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.